Actinium Pharmaceuticals, Inc. (ATNM)

1.780.01 (-0.56%)

Actinium Pharmaceuticals, Inc. (ATNM) stock comprehensive Balance Sheet Growth Analysis including assets, liabilities, and equity growth. Compare balance sheet against peers/competitors, industry and sector standards.

High Bankruptcy RiskBelow Average ESGFair ValuationLow ProfitabilityAdequate Financial HealthInefficient OperationsModerate GrowthLow QualityAdequate Dividend ProfileIndustry Rank: 20.71%Sector Rank: 20.27%

AMEX - Healthcare - Biotechnology | Market Cap: 55.53M | Next Earnings Date: 13 Nov 2025

Day's Range

1.75 - 1.81

52-Week Range

1.03 - 2.41

Volume

122.5K / 297.6K (Avg.)

P/E Ratio | EPS

-1.36 | -1.31

Trending:

ATNM Balance Sheet Growth Analysis

Compare against a Competitor

None AGEN AVXL RVPH AXSM TRAW

Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.

Cash & Equivalents Growth

13.37%

Decreased from previous period

Cash & equivalents changing by 13.37% while Healthcare maintains stable levels. Benjamin Graham would examine if this divergence is justified.

Short-Term Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Cash + Short-Term Investments Growth

13.37%

Decreased from previous period

Cash + STI yoy growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.

Net Receivables Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Other Current Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Current Assets Growth

12.78%

Decreased from previous period

Current assets growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a potential liquidity edge if well allocated.

PP&E (Net) Growth

-7.38%

Increased from previous period

PP&E growth below half of Healthcare median of 0.00%. Jim Chanos would suspect potential underinvestment or strategic shift away from core assets.

Goodwill Growth

No Data

No Data available this quarter, please select a different quarter.

Intangible Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Goodwill + Intangibles Growth

No Data

No Data available this quarter, please select a different quarter.

Long-Term Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Tax Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Current Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Assets Growth

-4.96%

Increased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos sees a sharp divergence from peers, possibly a sign of strategic retreat or capital shortage.

Other Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Assets Growth

12.46%

Decreased from previous period

≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees more aggressive asset expansion than peers, but must confirm returns are adequate.

Accounts Payable Growth

-8.08%

Increased from previous period

Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.

Short-Term Debt Growth

2.29%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.

Tax Payables Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Revenue (Current) Growth

8.08%

Decreased from previous period

≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a robust subscription base vs. peers.

Other Current Liabilities Growth

-2.29%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.

Total Current Liabilities Growth

-6.99%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects potential working capital strain.

Long-Term Debt Growth

No Data

No Data available this quarter, please select a different quarter.

Non-Current Deferred Revenue Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Tax Liabilities (Non-Current) Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Current Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Liabilities Growth

-58.38%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a red flag in ballooning future obligations.

Other Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Liabilities Growth

-9.31%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects an alarming rise in overall leverage.

Common Stock (Book Value) Growth

10.53%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.

Retained Earnings Growth

-2.12%

Increased from previous period

≥ 1.5x Healthcare median of -0.54%. Joel Greenblatt sees stronger retained profit growth vs. peers.

AOCI Growth

-7.96%

Above 1.5x Healthcare median 0.00%. Jim Chanos suspects a red flag if these gains are highly volatile.

Other Stockholders' Equity Items Growth

No Data

No Data available this quarter, please select a different quarter.

Total Stockholders' Equity Growth

13.80%

Decreased from previous period

≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees stronger equity growth vs. peers.

Liabilities + Equity Growth

12.46%

Decreased from previous period

≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees more aggressive expansions than peers.

Total Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Total Debt Growth

-16.56%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.

Net Debt Growth

-13.63%

Increased from previous period

Above 1.5x Healthcare median 0.00%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric:

ATNM Balance Sheet Growth Analysis

Compare against a Competitor

None AGEN AVXL RVPH AXSM TRAW

Cash & Equivalents Growth

13.37%

Decreased from previous period

Cash & equivalents changing by 13.37% while Healthcare maintains stable levels. Benjamin Graham would examine if this divergence is justified.

Short-Term Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Cash + Short-Term Investments Growth

13.37%

Decreased from previous period

Cash + STI yoy growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.

Net Receivables Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Other Current Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Current Assets Growth

12.78%

Decreased from previous period

Current assets growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a potential liquidity edge if well allocated.

PP&E (Net) Growth

-7.38%

Increased from previous period

PP&E growth below half of Healthcare median of 0.00%. Jim Chanos would suspect potential underinvestment or strategic shift away from core assets.

Goodwill Growth

No Data

No Data available this quarter, please select a different quarter.

Intangible Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Goodwill + Intangibles Growth

No Data

No Data available this quarter, please select a different quarter.

Long-Term Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Tax Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Current Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Assets Growth

-4.96%

Increased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos sees a sharp divergence from peers, possibly a sign of strategic retreat or capital shortage.

Other Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Assets Growth

12.46%

Decreased from previous period

≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees more aggressive asset expansion than peers, but must confirm returns are adequate.

Accounts Payable Growth

-8.08%

Increased from previous period

Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.

Short-Term Debt Growth

2.29%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.

Tax Payables Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Revenue (Current) Growth

8.08%

Decreased from previous period

≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a robust subscription base vs. peers.

Other Current Liabilities Growth

-2.29%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.

Total Current Liabilities Growth

-6.99%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects potential working capital strain.

Long-Term Debt Growth

No Data

No Data available this quarter, please select a different quarter.

Non-Current Deferred Revenue Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Tax Liabilities (Non-Current) Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Current Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Liabilities Growth

-58.38%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a red flag in ballooning future obligations.

Other Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Liabilities Growth

-9.31%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects an alarming rise in overall leverage.

Common Stock (Book Value) Growth

10.53%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.

Retained Earnings Growth

-2.12%

Increased from previous period

≥ 1.5x Healthcare median of -0.54%. Joel Greenblatt sees stronger retained profit growth vs. peers.

AOCI Growth

-7.96%

Above 1.5x Healthcare median 0.00%. Jim Chanos suspects a red flag if these gains are highly volatile.

Other Stockholders' Equity Items Growth

No Data

No Data available this quarter, please select a different quarter.

Total Stockholders' Equity Growth

13.80%

Decreased from previous period

≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees stronger equity growth vs. peers.

Liabilities + Equity Growth

12.46%

Decreased from previous period

≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees more aggressive expansions than peers.

Total Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Total Debt Growth

-16.56%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.

Net Debt Growth

-13.63%

Increased from previous period

Above 1.5x Healthcare median 0.00%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric: